<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02575664</url>
  </required_header>
  <id_info>
    <org_study_id>KUH2011-000692-14</org_study_id>
    <nct_id>NCT02575664</nct_id>
  </id_info>
  <brief_title>Effects of Low Dose Buprenorphine on Recovery After Hip or Knee Arthroplasty</brief_title>
  <acronym>lonkkalaasta</acronym>
  <official_title>Effects of Low Dose Buprenorphine on Recovery After Hip or Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Eastern Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kuopio University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Buprenorphine is a highly lipophilic thebaine derivative that appears to have high affinity
      for mu-, kappa-, and delta-opioid receptors and low affinity for opioid receptors like 1
      -receptors. It acts as a partial agonist at the mu-opioid and as a partial agonist/antagonist
      at the kappa-opioid, and as an antagonist at the delta opioid receptors. Buprenorphine has up
      to two-fold duration of action and it is approximately 30-fold more potent when compared to
      morphine.

      Pain is a common problem in patients coming to joint arthroplastic surgery. Buprenorphine low
      dose patches are recommended for treatment of moderate pain for example osteoarthritis pain.
      It is known that well treated pain even preoperatively may prevent prolonged postsurgical
      pain.

      In the present study the effects of low dose buprenorphine on postoperative pain and recovery
      were assessed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain relief</measure>
    <time_frame>time from drug patch administration up to five weeks</time_frame>
    <description>Brief pain inventory</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prolonged pain after arthroplastic surgery</measure>
    <time_frame>from time from drug patch administration up to one year</time_frame>
    <description>Brief pain inventory</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Pain</condition>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Buprenorphine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Buprenorphine 5 microg/h/7days patch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo patch</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Buprenorphine</intervention_name>
    <description>Buprenorphine 5 microg/h/7 days</description>
    <arm_group_label>Buprenorphine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo patch</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  no pregnancy/lactation, reliable contraception before menopause

          -  elective knee or hip arthroplasty surgery

          -  BMI (=body mass index) 18-35 kg/m2

          -  obtained informed consent

        Exclusion Criteria:

          -  buprenorphine medication

          -  allergy to study drugs• ikä &lt; 18 tai &gt;75 years

               -  BMI &lt;18 tai&gt;35 kg/m2

               -  weight below 50 kg

               -  Other contraindication for the study drug
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Merja Kokki, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kuopio University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <state>Northern Savo</state>
        <zip>70029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 9, 2015</study_first_submitted>
  <study_first_submitted_qc>October 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2015</study_first_posted>
  <last_update_submitted>December 25, 2015</last_update_submitted>
  <last_update_submitted_qc>December 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kuopio University Hospital</investigator_affiliation>
    <investigator_full_name>Merja Kokki</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Arthroplasty</keyword>
  <keyword>Buprenorphine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Buprenorphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

